S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Biden To Unleash "Choke Point" Operation On America? (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Biden To Unleash "Choke Point" Operation On America? (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Biden To Unleash "Choke Point" Operation On America? (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Biden To Unleash "Choke Point" Operation On America? (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NASDAQ:QDEL

QuidelOrtho (QDEL) Stock Forecast, Price & News

$86.16
+0.51 (+0.60%)
(As of 06/2/2023 ET)
Compare
Today's Range
$85.92
$87.00
50-Day Range
$84.72
$94.16
52-Week Range
$66.88
$108.35
Volume
217,417 shs
Average Volume
435,747 shs
Market Capitalization
$5.74 billion
P/E Ratio
47.34
Dividend Yield
N/A
Price Target
$123.83

QuidelOrtho MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
43.7% Upside
$123.83 Price Target
Short Interest
Bearish
4.25% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.61
Upright™ Environmental Score
News Sentiment
1.19mentions of QuidelOrtho in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.69%
From $5.18 to $5.63 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Medical Sector

119th out of 983 stocks

Diagnostic Substances Industry

3rd out of 15 stocks


QDEL stock logo

About QuidelOrtho (NASDAQ:QDEL) Stock

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Stock News Headlines

The gold catalyst we've waited for
Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
StockNews.com Begins Coverage on QuidelOrtho (NASDAQ:QDEL)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Craig-Hallum Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
RBC Capital Remains a Buy on QuidelOrtho (QDEL)
QuidelOrtho (QDEL) Receives a Buy from Craig-Hallum
See More Headlines

QDEL Price History

QDEL Company Calendar

Last Earnings
11/04/2021
Today
6/02/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:QDEL
CUSIP
74838J10
Employees
7,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$123.83
High Stock Price Forecast
$173.00
Low Stock Price Forecast
$86.00
Forecasted Upside/Downside
+43.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$548.70 million
Pretax Margin
5.64%

Debt

Sales & Book Value

Annual Sales
$3.27 billion
Cash Flow
$18.45 per share
Book Value
$74.99 per share

Miscellaneous

Free Float
64,834,000
Market Cap
$5.74 billion
Optionable
Optionable
Beta
0.29

Social Links


Key Executives

  • Douglas C. BryantDouglas C. Bryant
    President, Chief Executive Officer & Director
  • Robert Joseph Bujarski
    Chief Operating Officer & Executive Vice President
  • Joseph Michael Busky
    Chief Financial Officer
  • Louise Brandy
    Chief Information Officer
  • Werner KrollWerner Kroll
    Senior Vice President-Research & Development













QDEL Stock - Frequently Asked Questions

Should I buy or sell QuidelOrtho stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" QDEL shares.
View QDEL analyst ratings
or view top-rated stocks.

What is QuidelOrtho's stock price forecast for 2023?

5 brokers have issued 1 year target prices for QuidelOrtho's shares. Their QDEL share price forecasts range from $86.00 to $173.00. On average, they anticipate the company's stock price to reach $123.83 in the next twelve months. This suggests a possible upside of 43.7% from the stock's current price.
View analysts price targets for QDEL
or view top-rated stocks among Wall Street analysts.

How have QDEL shares performed in 2023?

QuidelOrtho's stock was trading at $85.67 on January 1st, 2023. Since then, QDEL shares have increased by 0.6% and is now trading at $86.16.
View the best growth stocks for 2023 here
.

When is QuidelOrtho's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our QDEL earnings forecast
.

How were QuidelOrtho's earnings last quarter?

QuidelOrtho Co. (NASDAQ:QDEL) posted its quarterly earnings results on Thursday, November, 4th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.52 by $1.84. The company earned $509.70 million during the quarter, compared to analysts' expectations of $344.25 million. QuidelOrtho had a trailing twelve-month return on equity of 10.25% and a net margin of 3.78%. QuidelOrtho's revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.68 earnings per share.

What guidance has QuidelOrtho issued on next quarter's earnings?

QuidelOrtho updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $5.15-$5.70 for the period, compared to the consensus earnings per share estimate of $5.23. The company issued revenue guidance of $2.87 billion-$3.18 billion, compared to the consensus revenue estimate of $2.95 billion.

What is Doug Bryant's approval rating as QuidelOrtho's CEO?

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

What other stocks do shareholders of QuidelOrtho own?

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

What is QuidelOrtho's stock symbol?

QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL."

Who are QuidelOrtho's major shareholders?

QuidelOrtho's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.50%), ArrowMark Colorado Holdings LLC (4.93%), State Street Corp (2.31%), JPMorgan Chase & Co. (1.80%), Neuberger Berman Group LLC (1.73%) and Alyeska Investment Group L.P. (1.72%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends
.

How do I buy shares of QuidelOrtho?

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QuidelOrtho's stock price today?

One share of QDEL stock can currently be purchased for approximately $86.16.

How much money does QuidelOrtho make?

QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $5.74 billion and generates $3.27 billion in revenue each year. The company earns $548.70 million in net income (profit) each year or $1.82 on an earnings per share basis.

How many employees does QuidelOrtho have?

The company employs 7,000 workers across the globe.

How can I contact QuidelOrtho?

QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (800) 874-1517, via email at rargueta@quidel.com, or via fax at 858-453-4338.

This page (NASDAQ:QDEL) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -